UltraGreen.ai share-price plunge tests SGX’s push for IPO variety

Specialised risks: Workers walk past the reception area of the SGX headquarters in Singapore. The exchange says it is important not to extrapolate the performance of any single company to an entire sector. — Bloomberg

SINGAPORE: Singapore-listed medical technology company UltraGreen.ai’s shares have more than halved since its listing nine months ago, testing the Singapore Exchange’s (SGX) push to attract a greater variety of initial public offerings (IPOs) and underscoring the need for investors to understand the specialised risks before buying into unfamiliar businesses.

The counter last traded at 68.5 US cents on Aug 31, less than half its value when it commenced trading on the SGX mainboard at US$1.45 on Dec 3, 2025.